Lyophilized Injectable Market Size, Trends, Forecast - 2028
The lyophilized injectable market is projected to reach US$ 4,001.27 million by 2028 from US$ 2,719.42 million in 2021; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.
Key factors driving the market are increasing demand for contract research manufacturing services, rising approvals of pharmaceuticals, and growing demand for biologics. However, product recalls restrain the market growth.
Lyophilized injectable are freeze-dried drugs that are stable during transportation. They are stored in single-use vials, point-of-care reconstitution, and specialty packaging for a longer period. At the time of use, required quantity of drugs can be reconstituted with the help of diluents. Lyophilized injectables are also termed as freeze-dried injectable as they are manufactured by the lyophilization process, a technique of isolating a solid material from a solvent by freezing and evaporating the solution under vacuum. Lyophilized injections are often considered as best alternative to oral solid dosage forms. In many case studies, the injections have immensely benefitted bedridden patients. Lyophilized injections are also prescribed to attain maximum bioavailability and stability in patients suffering from several diseases as these injectables have a longer shelf life than other dosage forms.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Lyophilized Injectable Market: Strategic Insights
Market Size Value in US$ 2,719.42 Million in 2021 Market Size Value by US$ 4,001.27 Million by 2028 Growth rate CAGR of 5.8% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Lyophilized Injectable Market: Strategic Insights
| Market Size Value in | US$ 2,719.42 Million in 2021 |
| Market Size Value by | US$ 4,001.27 Million by 2028 |
| Growth rate | CAGR of 5.8% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Approvals of Pharmaceuticals Drive Market Growth
Ongoing studies are emerging about the safety and efficacy of novel lyophilized therapeutic agents used in hospitalized adult patients diagnosed with COVID-19. Manufacturers in the global lyophilized injectable market are taking approvals from the US FDA for the emergency use authorization (EUA) of such innovations to treat patients suffering from severe COVID-19 symptoms.
Since the COVID-19 pandemic, players in the global lyophilized injectable market are increasing efforts to gain approval by regulatory organizations, such as the Drug Controller General of India (DCGI), for restricted emergency use in India. The growing approvals for pharmaceuticals, such as Remdesivir, eventually lead to the high demand for lyophilized injectables. Following are a few instances of pharmaceuticals approved by the FDA and other regulatory bodies.
- In February 2020, Mylan secured regulatory approval from DCGI for Remdesivir lyophilized powder in India for restricted emergency use in COVID-19 patients.
- In June 2020, Cipla launched Cipremi, Remdesivir lyophilized powder for injection. Also, the US FDA issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc. for emergency use of Remdesivir to treat hospitalized COVID-19 patients. It is the only FDA-approved EUA treatment for adult and pediatric patients hospitalized with suspected or laboratory-confirmed COVID-19 infection. Thus, in May, Gilead Sciences Inc. extended a voluntary nonexclusive license to Cipla to manufacture and market Cipla’s generic version of remedisvir called CIPREMI.
- In July 2020, Jubilant Life received approval from the Drug Controller General of India (DCGI) to manufacture and market Remdesivir for 100 mg/vial (lyophilized injection) for restricted emergency use in India for the treatment of severe COVID-19.
- In August 2020, Cosentyx lyophilized powder in a single-use vial by Novartis AG received EU approval. The drug approved was highly productive in rapidly improving skin symptoms and improving the quality of patient’s life suffering from psoriasis.
Thus, the increasing approvals across the world propel the growth of the lyophilized injectables market.
Type of Packaging -Based Insights
The global lyophilized injectable market, based on type of packaging, is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. In 2021, the single-use vials segment accounted for the largest market share, whereas the specialty packaging segment is expected to register the highest CAGR of 6.7% during the forecast period.
Type of Delivery -Based Insights
Based on type of delivery, the global lyophilized injectable market is segmented into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.3% during the forecast period.
Indication-Based Insights
Based on indication, the global lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune disease , and other indications. The metabolic and oncology conditions segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.2% during the forecast period.
End User-Based Insights
Based on end user, the global lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2021. However, the specialty clinics segment is estimated to register the highest CAGR of 6.3% in the market during the forecast period.
Companies operating in the global lyophilized injectable market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market. For instance, in April 2022, Recipharm acquired advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisition also enabled Recipharm to establish a robust base in the US, with facilities in Boxborough, MA, and provide a platform from which to build its capabilities in new biologics modalities.
Lyophilized Injectable Market Report Scope
Global Lyophilized Injectable Market – by Geography
Geographically, the global lyophilized injectable market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, and the Rest of APAC), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
- Baxter
- Nipro
- Curia Global, Inc.
- Recipharm AB
- Vetter Pharma
- Jubilant HollisterStier LLC (Jubilant Pharma Limited)
- Aristopharma Ltd.
- CordenPharma International
- Credence MedSystems, Inc.
- S. G. Biopharm Pvt. Ltd
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type of Packaging, Type of Delivery, Indication, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global lyophilized injectable market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for lyophilized injectable market. The growth of the market in North America is expected due to the factors such as increasing demand for lyophilized injectable for safer packaging and prolonged shelf life, growing pharmaceutical production due to pandemic, and rising research and development in the healthcare industry. Further, the growing research & development activities owing to the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and the rise in the research & applications of the lyophilized injectable drug in various fields are the key factors responsible for the Asia-Pacific regional growth for lyophilized injectable accounting for the fastest growth of the region during the coming years.
Baxter, Nipro, Curia Global, Inc., Recipharm AB, Vetter Pharma, Jubilant HollisterStier (Jubilant Pharma Limited), Aristopharma Ltd., CordenPharma International, Credence MedSystems, Inc., and S. G. Biopharm Pvt. Ltd. are among the leading companies operating in the lyophilized injectable market.
Based on end user, hospital segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
The metabolic and oncology conditions segment dominated the indication segment in the global lyophilized injectable market and accounted for the largest market share of 46.05% in 2021.
Based on type of delivery, prefilled diluent syringes segment accounted for the largest share in 2021 in the worldwide market and is expected to continue to do so till the forecast period.
Lyophilized injectables are freeze-dried drugs that are more stable and can be transported and stored for a longer period. At the time of use, the required quantity of drugs can be reconstituted with the help of diluents. Lyophilized injectable are also termed as freeze-dried injectable as they are produced by the lyophilization process which is the technique of isolating a solid material from a solvent by freezing and evaporating the solution under vacuum. The lyophilized injectable market is segmented into type of packaging, type of delivery, indication, end user, and geography.
Increasing demand of contract research manufacturing services and rising approvals of pharmaceuticals are the most significant factors responsible for the overall market growth.
Based on type of packaging, single-use vials segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Lyophilized Injectable Market – By Type of Packaging
1.3.2 Global Lyophilized Injectable Market – By Type of Delivery
1.3.3 Global Lyophilized Injectable Market – By Indication
1.3.4 Global Lyophilized Injectable Market – By End User
1.3.5 Global Lyophilized Injectable Market – By Geography
2. Lyophilized Injectable Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Lyophilized Injectable Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Lyophilized Injectable Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Contract Research Manufacturing Services
5.1.2 Rising Approvals of Pharmaceuticals
5.1.3 Increasing Demand of Biologics
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
5.4 Future Trends
5.4.1 Advancement in Lyophilized Packaging
5.5 Impact Analysis
6. Lyophilized Injectable Market– Global Analysis
6.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
6.1.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
6.1.2 Global Lyophilized Injectable Market – Market Potential Analysis, by Region
6.2 Comparative Company Analysis
6.3 Growth Strategy Analysis
6.4 Market Positioning Analysis of Key Players in Lyophilized Injectable Market
6.5 Performance of Key Players
6.5.1.1 Baxter International
6.5.1.2 Nipro
6.6 Market Share Analysis
6.7 Top 3 Lyophilized Drug Products (ASP) (2021)
7. Lyophilized Injectable Market Analysis – By Type of Packaging
7.1 Overview
7.2 Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
7.3 Single-use vials
7.3.1 Overview
7.3.2 Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Point-of-Care Reconstitution
7.4.1 Overview
7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Specialty Packaging
7.5.1 Overview
7.5.2 Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8. Lyophilized Injectable Market Analysis – By Type Of Delivery
8.1 Overview
8.2 Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
8.3 Prefilled Diluent Syringes
8.3.1 Overview
8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Single Step Devices
8.4.1 Overview
8.4.2 Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Proprietary Reconstitution Devices
8.5.1 Overview
8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multi-Step Devices
8.6.1 Overview
8.6.2 Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
9. Lyophilized Injectable Market Analysis – By Indication
9.1 Overview
9.2 Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
9.3 Metabolic and Oncology Conditions
9.3.1 Overview
9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
9.4.1 Overview
9.4.2 Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Indications
9.6.1 Overview
9.6.2 Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
10. Lyophilized Injectable Market –By End User
10.1 Overview
10.2 Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11. Lyophilized Injectable Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America: Lyophilized Injectable Market
11.1.1 Overview
11.1.2 North America: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)
11.1.4 North America: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.1.5 North America: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.1.6 North America: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.1.7 North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)
11.1.7.1.4 US: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.1.7.1.5 US: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.1.7.1.6 US: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)
11.1.7.2.4 Canada: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.1.7.2.5 Canada: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.1.7.2.6 Canada: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.1.7.3 Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ Million)
11.1.7.3.4 Mexico: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.1.7.3.5 Mexico: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.1.7.3.6 Mexico: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.2 Europe: Lyophilized Injectable Market
11.2.1 Overview
11.2.2 Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.3 Europe: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.4 Europe: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.5 Europe: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.6 Europe: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.2.7 Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.1.1 Overview
11.2.7.1.1 Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.1.2 Germany: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.7.1.3 Germany: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.7.1.4 Germany: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.7.1.5 Germany: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.2.7.2 UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.2.1 Overview
11.2.7.2.2 UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.2.3 UK: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.7.2.4 UK: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.7.2.5 UK: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.7.2.6 UK: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.2.7.3 France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.3.3 France: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.7.3.4 France: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.7.3.5 France: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.7.3.6 France: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.2.7.4 Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.4.3 Italy: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.7.4.4 Italy: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.7.4.5 Italy: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.7.4.6 Italy: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.2.7.5 Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.5.3 Spain: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.7.5.4 Spain: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.7.5.5 Spain: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.7.5.6 Spain: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.2.7.6 Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.2.7.6.3 Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.2.7.6.4 Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.2.7.6.5 Rest of Europe: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.2.7.6.6 Rest of Europe: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.3 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts To 2028
11.3.1 Overview
11.3.2 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.4 Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.5 Asia Pacific: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.6 Asia Pacific: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.3.7 Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.7.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.7.1.5 China: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.7.1.6 China: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.3.7.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.7.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.7.2.5 India: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.7.2.6 India: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.3.7.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.7.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.7.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.7.3.6 Japan: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.3.7.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.7.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.7.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.7.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.3.7.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.7.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.7.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.7.5.6 Australia: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Lyophilized Injectable Market, by End User, 2019–2028 (US$ Million)
11.4 South and Central America Lyophilized Injectable Market
11.4.1 Overview
11.4.2 South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
11.4.3 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
11.4.4 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
11.4.5 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
11.4.6 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
11.4.7 South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.4.7.1 Brazil: Lyophilized Injectable Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Overview
11.4.7.1.2 Brazil Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.3 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
11.4.7.1.4 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
11.4.7.1.5 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
11.4.7.1.6 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
11.4.7.2 Argentina: Lyophilized Injectable Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 Overview
11.4.7.2.2 Argentina Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.3 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
11.4.7.2.4 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
11.4.7.2.5 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
11.4.7.2.6 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
11.4.7.3 Rest of the South and Central America: Lyophilized Injectable Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 Overview
11.4.7.3.2 Rest of the South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.3 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
11.4.7.3.4 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
11.4.7.3.5 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
11.4.7.3.6 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5 Middle East & Africa Lyophilized Injectable Market Revenue and Forecasts To 2028
11.5.1 Overview
11.5.2 Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.3 Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging, 2019–2028 (US$ ‘Million)
11.5.4 Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery, 2019–2028 (US$ ‘Million)
11.5.5 Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.5.6 Middle East and Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.5.7 Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.5.7.1 South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.1.1 Overview
11.5.7.1.2 South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.1.3 South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)
11.5.7.1.4 South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)
11.5.7.1.5 South Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.5.7.1.6 South Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.5.7.2 Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.2.1 Overview
11.5.7.2.2 Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.2.3 Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)
11.5.7.2.4 Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)
11.5.7.2.5 Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.5.7.2.6 Saudi Arabia: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.5.7.3 UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.3.1 Overview
11.5.7.3.2 UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.3.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)
11.5.7.3.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)
11.5.7.3.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.5.7.3.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
11.5.7.4 Rest of Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.4.1 Overview
11.5.7.4.2 Rest of Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.5.7.4.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019–2028 (US$ ‘Million)
11.5.7.4.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019–2028 (US$ ‘Million)
11.5.7.4.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019–2028 (US$ ‘Million)
11.5.7.4.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019–2028 (US$ ‘Million)
12. Impact of COVID-19 Pandemic on Global Lyophilized Injectable Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13. Lyophilized Injectable Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Lyophilized Injectable Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Baxter
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Nipro
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Curia Global, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Recipharm AB
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Vetter Pharma
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Jubilant HollisterStier (Jubilant Pharma Limited)
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Aristopharma Ltd.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 CordenPharma International
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Credence MedSystems, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 S.G. Biopharm Pvt. Ltd.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Top 3 Lyophilized Drug Products ((Global Average Selling Price (ASP)) (2021)
Table 2. North America Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 19. Europe: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 20. Europe: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 21. Europe: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 22. Germany: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 23. Germany: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 24. Germany: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 25. Germany: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 26. UK: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 27. UK: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 28. UK: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 29. UK: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 30. France: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 31. France: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 32. France: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 33. France: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 34. Italy: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 35. Italy: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 36. Italy: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 37. Italy: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 38. Spain: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 39. Spain: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 40. Spain: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 41. Spain: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 42. Rest of Europe: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 43. Rest of Europe: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 44. Rest of Europe: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 45. Rest of Europe: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 46. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million).
Table 47. Asia Pacific: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 50. China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 51. China: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 52. China: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 53. China: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 54. India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 55. India: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 56. India: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 59. Japan: Lyophilized Injectable Market, by Type of Delivery– Revenue and Forecast to 2028 (US$ Million)
Table 60. Japan: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. Japan: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 62. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 63. South Korea: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 67. Australia: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 68. Australia: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 69. Australia: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 71. Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Asia Pacific: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 74. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
Table 75. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
Table 76. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
Table 77. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 78. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
Table 79. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
Table 80. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
Table 81. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 82. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
Table 83. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
Table 84. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
Table 85. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 86. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
Table 87. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
Table 88. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
Table 89. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 90. Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 91. Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 92. Middle East and Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 93. Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 94. South Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 ( US$ ‘Million)
Table 95. South Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 96. South Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 97. South Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 98. Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 99. Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 100. Saudi Arabia: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 101. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 102. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 103. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 104. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 105. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 106. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging – Revenue and Forecast to 2028 (US$ ‘Million)
Table 107. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery – Revenue and Forecast to 2028 (US$ ‘Million)
Table 108. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 109. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 110. Recent Inorganic Growth Strategies in the Lyophilized Injectable Market
Table 111. Recent Organic Growth Strategies in the Lyophilized Injectable Market
Table 112. Glossary of Terms, Lyophilized Injectable Market
LIST OF FIGURES
Figure 1. Lyophilized Injectable Market Segmentation
Figure 2. Lyophilized Injectable Market – By Geography
Figure 3. Lyophilized Injectable Market Overview
Figure 4. Single-Use Vials Segment Held Largest Share by Type of Packaging in Lyophilized Injectable Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Lyophilized Injectable Market, by Geography (US$ Million)
Figure 7. Global Lyophilized Injectable Market – Leading Country Markets (US$ Million)
Figure 8. Global Lyophilized Injectable Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Lyophilized Injectable Market Impact Analysis of Drivers and Restraints
Figure 16. Global Lyophilized Injectable Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Lyophilized Injectable Market– Revenue Forecast And Analysis – 2022 - 2028
Figure 18. Global Lyophilized Injectable Market – Market Potential Analysis, by Region
Figure 19. Global Lyophilized Injectable Market – Comparative Company Analysis
Figure 20. Global Lyophilized Injectable Market – Growth Strategy Analysis
Figure 21. Market Positioning Analysis of Key Players in Global Lyophilized Injectable Market
Figure 22. Market Share Analysis of Key Players in Global Lyophilized Injectable Market
Figure 23. Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
Figure 24. Single-use vials: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Point-of-Care Reconstitution: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Specialty Packaging: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
Figure 28. Prefilled Diluent Syringes: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Single Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Proprietary Reconstitution Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Multi-Step Devices: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
Figure 33. Metabolic and Oncology Conditions: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Infectious Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Autoimmune Diseases: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Other Indications: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
Figure 38. Hospitals: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Ambulatory Surgical Centers: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Specialty Clinics: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End Users: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America: Lyophilized Injectable Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. North America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 45. US: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Canada: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Mexico: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Europe: Lyophilized Injectable Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 49. Europe: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 50. Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 51. Germany: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 52. UK: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 53. France: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 54. Italy: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 55. Spain: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 56. Rest of Europe: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 57. Asia Pacific Lyophilized Injectable Market Overview, by Country (2021)
Figure 58. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 60. China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. Rest of Asia Pacific: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South and Central America Lyophilized Injectable Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 67. South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 69. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
Figure 72. Middle East and Africa: Lyophilized Injectable Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 73. Middle East and Africa: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 74. Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 75. South Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 76. Saudi Arabia: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 77. UAE: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 78. Rest of Middle East and Africa: Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 79. Impact of COVID-19 Pandemic in North American Country Markets
Figure 80. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 81. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 82. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 83. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 84. Growth Strategies in the Lyophilized Injectable Market
The List of Companies - Lyophilized Injectable Drugs Market
- Baxter
- Nipro
- Curia Global, Inc.
- Recipharm AB
- Vetter Pharma
- Jubilant HollisterStier LLC (Jubilant Pharma Limited)
- Aristopharma Ltd.
- CordenPharma International
- Credence MedSystems, Inc.
- S. G. Biopharm Pvt. Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For